Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

Taking a GLP-1 medication? A guide for what to avoid during the holiday season — and how to still enjoy dessert ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

A new scientific review reveals that certain plant-based foods can mimic the GLP-1-boosting effects of Ozempic, helping ...

The effects of Ozempic on grocery spending are obvious; the Harvard Business Review found GLP-1 households are spending up to ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

Spending on diabetes medication in the Netherlands has increased by a staggering 76 percent between 2020 and 2024. New users ...

Dr Terry Dubrow announced a new Ozempic-related disorder, which he called 'Ozempic penis,' where one's member 'looks bigger' ...